$NXPT
Nexpoint Capital Inc

2023 Q4 Form 10-K Financial Statement

#000119312524080440 Filed on March 28, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $109.7K $1.654M $113.6K
YoY Change -3.44% -7.58% -5253.33%
Cost Of Revenue $263.7K $1.167M
YoY Change -17.09%
Gross Profit $276.5K $2.165M
YoY Change -5.24%
Gross Profit Margin 251.99% 130.91%
Selling, General & Admin $140.2K $388.2K
YoY Change 1.76%
% of Gross Profit 50.69% 17.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $179.8K $2.099M
YoY Change -7.96%
Operating Profit $96.70K $66.05K
YoY Change 1417.93%
Interest Expense $1.733M -$213.0K
YoY Change
% of Operating Profit 1791.64% -322.49%
Other Income/Expense, Net $123.0K
YoY Change 8.05%
Pretax Income $1.829M $1.441M
YoY Change -135.45%
Income Tax -$13.02K -$13.02K
% Of Pretax Income -0.71% -0.9%
Net Earnings $1.842M $1.454M $370.7K
YoY Change 396.95% -64.23%
Net Earnings / Revenue 1679.05% 87.91% 326.24%
Basic Earnings Per Share $0.19 $0.15 $0.04
Diluted Earnings Per Share $0.19 $0.15 $0.04
COMMON SHARES
Basic Shares Outstanding 9.309M 9.533M 9.678M
Diluted Shares Outstanding 9.533M

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.402M $1.402M
YoY Change -14.0%
Cash & Equivalents $1.402M $1.402M $1.630M
Short-Term Investments
Other Short-Term Assets $5.270K $5.270K
YoY Change -66.88%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.853M $1.853M
YoY Change -5.39%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $84.00 $49.41M $2.422M
YoY Change -100.0% -7.28% -64.83%
Other Assets $13.02K $13.02K
YoY Change
Total Long-Term Assets $49.43M $49.43M
YoY Change -7.26%
TOTAL ASSETS
Total Short-Term Assets $1.853M $1.853M
Total Long-Term Assets $49.43M $49.43M
Total Assets $51.28M $51.28M $55.25M
YoY Change -7.19% -7.19% -14.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $293.5K $293.5K
YoY Change -21.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.470M $1.470M
YoY Change -5.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.470M $1.470M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.470M $1.470M $1.558M
YoY Change -5.66% -5.66% -5.49%
SHAREHOLDERS EQUITY
Retained Earnings -$33.42M -$33.26M
YoY Change 0.47% 17.93%
Common Stock $9.309K $9.678K
YoY Change -3.81% -2.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $49.81M $49.81M $53.69M
YoY Change
Total Liabilities & Shareholders Equity $51.28M $51.28M
YoY Change -7.19%

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income $1.842M $1.454M $370.7K
YoY Change 396.95% -64.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $136.1K $5.144M
YoY Change 27.85%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $2.293M
YoY Change -2.09%
Common Stock Issuance & Retirement, Net $3.079M
YoY Change 7.55%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.085M -5.372M
YoY Change 3.21%
NET CHANGE
Cash From Operating Activities 136.1K 5.144M
Cash From Investing Activities
Cash From Financing Activities -1.085M -5.372M
Net Change In Cash -949.0K -228.1K
YoY Change -80.69%
FREE CASH FLOW
Cash From Operating Activities $136.1K $5.144M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1401744
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1629846
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001588272
CY2023Q4 dei Entity Public Float
EntityPublicFloat
0
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
814-01074
CY2023 dei Entity Registrant Name
EntityRegistrantName
NexPoint Capital, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3926499
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
300 Crescent Court, Suite 700
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75201
CY2023 dei City Area Code
CityAreaCode
972
CY2023 dei Local Phone Number
LocalPhoneNumber
628-4100
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9309405
CY2023 dei Auditor Firm
AuditorFirmId
925
CY2023 dei Auditor Name
AuditorName
Cohen & Company, LTD.
CY2023 dei Auditor Location
AuditorLocation
Cleveland, Ohio, United States
CY2023Q4 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
8953
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
0
CY2023Q4 us-gaap Dividend And Interest Receivable
DividendAndInterestReceivable
299110
CY2022Q4 us-gaap Dividend And Interest Receivable
DividendAndInterestReceivable
220194
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
5273
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
15905
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13020
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0
CY2023Q4 us-gaap Assets
Assets
51279034
CY2022Q4 us-gaap Assets
Assets
55251876
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
53304
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
0
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
293462
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
371736
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
837846
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
870980
CY2023Q4 us-gaap Liabilities
Liabilities
1469508
CY2022Q4 us-gaap Liabilities
Liabilities
1557709
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9309405
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9309405
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9677593
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9677593
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
9309
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9678
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
83221067
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86949376
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33420850
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33264887
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
49809526
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
53694167
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.35
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.55
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
1918030
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
2178971
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
3070371
CY2023 us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
131372
CY2022 us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
193003
CY2021 us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
100908
CY2023 us-gaap Fee Income
FeeIncome
0
CY2022 us-gaap Fee Income
FeeIncome
0
CY2021 us-gaap Fee Income
FeeIncome
4651
CY2023 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
3332223
CY2022 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
3692613
CY2021 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
4097859
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
942612
CY2022 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
1096487
CY2021 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
1220044
CY2023 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
311664
CY2022 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
311050
CY2021 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
307438
CY2023 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
194764
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
226948
CY2021 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
244754
CY2023 us-gaap Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
167547
CY2022 us-gaap Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
209866
CY2021 us-gaap Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
208251
CY2023 cik0001588272 Audit And Tax Fees
AuditAndTaxFees
166039
CY2022 cik0001588272 Audit And Tax Fees
AuditAndTaxFees
167864
CY2021 cik0001588272 Audit And Tax Fees
AuditAndTaxFees
168254
CY2023 cik0001588272 Reports To Stockholders
ReportsToStockholders
134324
CY2022 cik0001588272 Reports To Stockholders
ReportsToStockholders
82721
CY2021 cik0001588272 Reports To Stockholders
ReportsToStockholders
75060
CY2023 us-gaap Other Expenses
OtherExpenses
122992
CY2022 us-gaap Other Expenses
OtherExpenses
113825
CY2021 us-gaap Other Expenses
OtherExpenses
155670
CY2023 us-gaap Legal Fees
LegalFees
43949
CY2022 us-gaap Legal Fees
LegalFees
53658
CY2021 us-gaap Legal Fees
LegalFees
72441
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
15194
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
18170
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
17781
CY2023 us-gaap Operating Expenses
OperatingExpenses
2099085
CY2022 us-gaap Operating Expenses
OperatingExpenses
2280589
CY2021 us-gaap Operating Expenses
OperatingExpenses
2469693
CY2023 us-gaap Investment Company Voluntary Fee Waived
InvestmentCompanyVoluntaryFeeWaived
420776
CY2022 us-gaap Investment Company Voluntary Fee Waived
InvestmentCompanyVoluntaryFeeWaived
377594
CY2021 us-gaap Investment Company Voluntary Fee Waived
InvestmentCompanyVoluntaryFeeWaived
295261
CY2023 us-gaap Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
1678309
CY2022 us-gaap Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
1902995
CY2021 us-gaap Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
2174432
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
1653914
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
1789618
CY2021 us-gaap Net Investment Income
NetInvestmentIncome
1923427
CY2023 us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
-13020
CY2022 us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
0
CY2021 us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
0
CY2023 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
1666934
CY2022 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
1789618
CY2021 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
1923427
CY2023 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-212987
CY2022 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-5854792
CY2021 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
3782716
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1453947
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4065174
CY2021 us-gaap Net Income Loss
NetIncomeLoss
5706143
CY2023 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.17
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.18
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.19
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9533072
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9533072
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9893732
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9893732
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10254666
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10254666
CY2020Q4 us-gaap Assets Net
AssetsNet
64190472
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
1923427
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-3479546
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
7262262
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4643769
CY2021 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1319241
CY2021 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
3633179
CY2021 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-1251564
CY2021Q4 us-gaap Assets Net
AssetsNet
62938908
CY2021 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.36
CY2021Q4 us-gaap Assets Net
AssetsNet
62938908
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
1789618
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
329081
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-6183873
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2862936
CY2022 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1209200
CY2022 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
1526458
CY2022 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
1999373
CY2022 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-9244741
CY2022Q4 us-gaap Assets Net
AssetsNet
53694167
CY2022 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.36
CY2022Q4 us-gaap Assets Net
AssetsNet
53694167
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
1666934
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-4345706
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
4132719
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3079032
CY2023 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1127725
CY2023 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
1629804
CY2023 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
1757477
CY2023 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-3884641
CY2023Q4 us-gaap Assets Net
AssetsNet
49809526
CY2023 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.36
CY2023 us-gaap Profit Loss
ProfitLoss
1453947
CY2022 us-gaap Profit Loss
ProfitLoss
-4065174
CY2021 us-gaap Profit Loss
ProfitLoss
5706143
CY2023 cik0001588272 Purchases Of Investment Securities
PurchasesOfInvestmentSecurities
-4569498
CY2022 cik0001588272 Purchases Of Investment Securities
PurchasesOfInvestmentSecurities
-9519074
CY2021 cik0001588272 Purchases Of Investment Securities
PurchasesOfInvestmentSecurities
-8119981
CY2023 cik0001588272 Payment In Kind Investments
PaymentInKindInvestments
131372
CY2022 cik0001588272 Payment In Kind Investments
PaymentInKindInvestments
193003
CY2021 cik0001588272 Payment In Kind Investments
PaymentInKindInvestments
100908
CY2023 us-gaap Proceeds From Disposition Of Investment Operating Activity
ProceedsFromDispositionOfInvestmentOperatingActivity
8576616
CY2022 us-gaap Proceeds From Disposition Of Investment Operating Activity
ProceedsFromDispositionOfInvestmentOperatingActivity
11143514
CY2021 us-gaap Proceeds From Disposition Of Investment Operating Activity
ProceedsFromDispositionOfInvestmentOperatingActivity
17408129
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
4132719
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-6183873
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
7262262
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-208304
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
36426
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
87200
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.10
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-09-20
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-343633
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-972220
CY2023 cik0001588272 Increasedecreaseinreceivableforinvestmentssold
Increasedecreaseinreceivableforinvestmentssold
-8953
CY2022 cik0001588272 Increasedecreaseinreceivableforinvestmentssold
Increasedecreaseinreceivableforinvestmentssold
990537
CY2021 cik0001588272 Increasedecreaseinreceivableforinvestmentssold
Increasedecreaseinreceivableforinvestmentssold
-990537
CY2023 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
78916
CY2022 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-220210
CY2021 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
155192
CY2023 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
45432
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-3242
CY2021 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-6084
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10632
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2683
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13222
CY2023 us-gaap Increase Decrease In Payable For Investment Purchased
IncreaseDecreaseInPayableForInvestmentPurchased
53304
CY2022 us-gaap Increase Decrease In Payable For Investment Purchased
IncreaseDecreaseInPayableForInvestmentPurchased
-301369
CY2021 us-gaap Increase Decrease In Payable For Investment Purchased
IncreaseDecreaseInPayableForInvestmentPurchased
301369
CY2023 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-30097
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-63594
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-44950
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
13020
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-78274
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
299558
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-155884
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5143620
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4023323
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9086115
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3079032
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2862936
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4643769
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
2292690
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
2341712
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
2360642
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5371722
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5204648
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7004411
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-228102
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1181325
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2081704
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1629846
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2811171
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
729467
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1401744
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1629846
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2811171
CY2023 us-gaap Interest Paid Net
InterestPaidNet
131372
CY2022 us-gaap Interest Paid Net
InterestPaidNet
193003
CY2021 us-gaap Interest Paid Net
InterestPaidNet
100908
CY2023 cik0001588272 Reinvestment Of Distributions Paid
ReinvestmentOfDistributionsPaid
1127725
CY2022 cik0001588272 Reinvestment Of Distributions Paid
ReinvestmentOfDistributionsPaid
1209200
CY2021 cik0001588272 Reinvestment Of Distributions Paid
ReinvestmentOfDistributionsPaid
1319241
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
58473
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2000000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2000000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2000000
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
3.75
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0587
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-02-27
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1453650
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1450998
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1438750
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
7.50
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0536
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-09-30
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
658467
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
581366
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
514635
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.11
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-04-07
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
3000000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2945554
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3000000
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
4
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0538
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-07-01
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
333333
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
333679
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
261000
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
4
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0538
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-07-01
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1597232
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1599049
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1250633
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
6.75
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0564
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-06-26
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1555556
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1500056
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
127556
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6592574
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
1
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.08
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2025-03-25
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
463314
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
463314
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
463314
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.12
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.12
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
216696
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
216696
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
215938
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.12
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.12
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
915322
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
915322
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
912118
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.12
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.12
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
38714
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
38714
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
38579
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.12
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.12
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
36121
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
36121
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
35994
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1202629
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10258517
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
800
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
218666
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
84
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
84
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.045
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2029-03-15
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
500000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
482645
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
488665
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0638
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-05-01
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
116808
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
313455
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
99711
CY2023Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0838
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-05-01
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
214073
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
584792
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
139147
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
238858
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
727523
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
8500
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
17000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
42500
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
16534
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1563928
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2237604
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
750000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2062500
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3536250
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
131670
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2479467
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2073797
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
100000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1500000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2533000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4606797
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
23409
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
701237
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
805987
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
14035
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1599990
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4732181
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
15961319
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1700
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1700000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3016752
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
737
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
8418892
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7014774
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
371112
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
371111
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
338973
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7353747
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10370499
CY2023 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.10
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
750
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
750000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
686250
CY2023 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1000000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
500000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1186250
CY2023 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
135122
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1199993
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1644435
CY2023 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
72065
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
799994
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
928197
CY2023 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1863468
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4080000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4452382
CY2023 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1311091
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4000000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3611111
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10636125
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
11822375
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
5738
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
16122
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
133888
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
11051
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
5175
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
132612
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
266500
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2875
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
52987
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6469
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
272969
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
45998823
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
49413286
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1160707
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-764467
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
49809526
CY2023Q4 cik0001588272 Percentage Of Qualifying Assets To The Total Assets
PercentageOfQualifyingAssetsToTheTotalAssets
0.70
CY2023Q4 cik0001588272 Percentage Of Non Qualifying Asset On Companys Total Asset
PercentageOfNonQualifyingAssetOnCompanysTotalAsset
0.048
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
84
CY2023Q4 cik0001588272 Percentage Of Net Assets Under Valuation Procedure
PercentageOfNetAssetsUnderValuationProcedure
0
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
3.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0493
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-02-27
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1468909
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1465131
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1318346
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
6.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.1218
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-09-30
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
668605
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
576001
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
511483
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.14
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-04-07
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
3000000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2926520
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3000000
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
6.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0374
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2028-11-06
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1500000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1494084
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1422503
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.04
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-07-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
333333
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
333817
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
282500
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
4
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0441
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-07-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1613305
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1615775
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1367276
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
3.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0407
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2025-10-10
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
4518572
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
3709077
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1354645
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
4.50
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0211
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-12-20
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1993177
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1963107
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1888535
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
6.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0407
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-06-26
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1555556
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1481972
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1229869
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
5.50
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0441
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2025-10-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
984615
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
980197
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
783793
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
13158950
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.11
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
32189
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
32189
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
32002
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.11
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
193108
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
193108
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
191988
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.11
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
815685
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
815684
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
810953
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.11
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
34500
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
34500
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
34300
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1069243
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
14228193
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
800
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
218666
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7023
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
295435
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
169875
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
13
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7036
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7036
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.085
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-05-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2728000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2460536
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2414839
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.06375
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-05-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
116808
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
313455
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
107648
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.08375
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-05-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
214073
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
584792
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
182430
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
290078
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2704917
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
8500
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
17000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
42500
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
11534
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
981428
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1591692
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
750000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2062500
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1732500
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
481670
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
9960591
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7653730
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
100000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1500000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2359000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10012730
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
23409
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
698189
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1018779
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
237
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
253404
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2269
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
14035
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1599990
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5114214
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
19514684
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
2000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2000000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3088750
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
451112
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
451112
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
424468
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
100
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1215000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1176024
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1600492
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4689242
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.10
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
750
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
750000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
740625
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1000000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
700000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1440625
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
135122
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1199993
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1499989
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
72065
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
799994
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
799994
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1619048
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4080000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4549525
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1111111
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4000000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3677777
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10527285
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
11967910
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2029-08-27
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
5738
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
16122
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
64553
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2029-08-27
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
11051
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
5175
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
96696
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
161249
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2039-05-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2875
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
52987
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
20484
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
181733
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
54011971
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53293715
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1420428
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1019976
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53694167
CY2022Q4 cik0001588272 Percentage Of Qualifying Assets To The Total Assets
PercentageOfQualifyingAssetsToTheTotalAssets
0.70
CY2022Q4 cik0001588272 Percentage Of Non Qualifying Asset On Companys Total Asset
PercentageOfNonQualifyingAssetOnCompanysTotalAsset
0.048
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2421875
CY2022Q4 cik0001588272 Percentage Of Net Assets Under Valuation Procedure
PercentageOfNetAssetsUnderValuationProcedure
0.045
CY2023Q4 us-gaap Assets
Assets
51279034
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. </div>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1401744
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1629846
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
241037
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
209418
CY2022Q4 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
0
CY2023Q4 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
0
CY2023Q4 us-gaap Investment Sold Not Yet Purchased Percent Of Net Assets
InvestmentSoldNotYetPurchasedPercentOfNetAssets
0.25
CY2022Q4 us-gaap Investment Sold Not Yet Purchased Percent Of Net Assets
InvestmentSoldNotYetPurchasedPercentOfNetAssets
0.25
CY2023 us-gaap Fee Income
FeeIncome
0
CY2022 us-gaap Fee Income
FeeIncome
0
CY2021 us-gaap Fee Income
FeeIncome
4651
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
49413286
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
49413286
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
53293715
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
53293715
CY2022Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.09
CY2023Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.09
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Asset
FairValueDisclosureOffbalanceSheetRisksAmountAsset
0
CY2023Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Asset
FairValueDisclosureOffbalanceSheetRisksAmountAsset
0
CY2023 us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Recognition </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For loans with contractual PIK <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(payment-in-kind)</div></div> interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates. </div>
CY2023 cik0001588272 Offering Costs As A Percentage Of Total Proceeds Raised
OfferingCostsAsAPercentageOfTotalProceedsRaised
0.01
CY2022 cik0001588272 Offering Costs As A Percentage Of Total Proceeds Raised
OfferingCostsAsAPercentageOfTotalProceedsRaised
0.01
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1453947
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4065174
CY2021 us-gaap Net Income Loss
NetIncomeLoss
5706143
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9533072
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9533072
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9893732
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9893732
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10254666
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10254666
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
49413286
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53293715
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
45998823
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
49413286
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
54011971
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53293715
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
49413286
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53293715
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1
CY2023 cik0001588272 Base Management Fee Calculated Annual Rate Of Percentage Of Average Value Of Gross Assets
BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets
0.02
CY2023 cik0001588272 Investment Advisory Fee
InvestmentAdvisoryFee
942612
CY2022 cik0001588272 Investment Advisory Fee
InvestmentAdvisoryFee
1096487
CY2021 cik0001588272 Investment Advisory Fee
InvestmentAdvisoryFee
1220044
CY2023 cik0001588272 Maximum Recoupment Of Other Expenses Exceeds The Annual Rate Percentage Of Average Gross Assets
MaximumRecoupmentOfOtherExpensesExceedsTheAnnualRatePercentageOfAverageGrossAssets
0.034
CY2023 cik0001588272 Subordinated Incentive Fee On Income Is Determined And Payable Quarterly In Arrears Equals Percentage Of Pre Incentive Fee Net Investment Income
SubordinatedIncentiveFeeOnIncomeIsDeterminedAndPayableQuarterlyInArrearsEqualsPercentageOfPreIncentiveFeeNetInvestmentIncome
0.20
CY2023 cik0001588272 Hurdle Rate Expressed As Rate Of Return On Net Assets Equal To Percentage Per Quarter
HurdleRateExpressedAsRateOfReturnOnNetAssetsEqualToPercentagePerQuarter
0.01875
CY2023 us-gaap Investment Company Internal Rate Of Return Since Inception
InvestmentCompanyInternalRateOfReturnSinceInception
0.01875
CY2023Q4 cik0001588272 Pre Incentive Fee Net Investment Income For Quarter Equals Percentage Of Net Assets At The End Of Quarter
PreIncentiveFeeNetInvestmentIncomeForQuarterEqualsPercentageOfNetAssetsAtTheEndOfQuarter
0.0234375
CY2023Q4 cik0001588272 Catch Up Fee Receive By The Adviser Percentage Of The Pre Incentive Fee Net Investment Income From The Quarter
CatchUpFeeReceiveByTheAdviserPercentageOfThePreIncentiveFeeNetInvestmentIncomeFromTheQuarter
0.20
CY2023Q4 cik0001588272 Percentage Of Incentive Fee Capital Gains Is Determined And Payable In Arrears As At End Of Each Calender Year
PercentageOfIncentiveFeeCapitalGainsIsDeterminedAndPayableInArrearsAsAtEndOfEachCalenderYear
0.20
CY2023 cik0001588272 Incentive Fee Expense On Capital Gains
IncentiveFeeExpenseOnCapitalGains
0
CY2022 cik0001588272 Incentive Fee Expense On Capital Gains
IncentiveFeeExpenseOnCapitalGains
0
CY2021 cik0001588272 Incentive Fee Expense On Capital Gains
IncentiveFeeExpenseOnCapitalGains
0
CY2023Q4 cik0001588272 Aggregate Accrued Incentive Fees On Capital Gains
AggregateAccruedIncentiveFeesOnCapitalGains
0
CY2023 cik0001588272 Payment Of Incentive Fees With Respect To Realized Gains To The Adviser
PaymentOfIncentiveFeesWithRespectToRealizedGainsToTheAdviser
0
CY2023 cik0001588272 Minimum Reimbursement Amount As A Percentage Of Average Gross Assets
MinimumReimbursementAmountAsAPercentageOfAverageGrossAssets
0.004
CY2023 cik0001588272 Annual Rate Percentage Of Average Gross Assets
AnnualRatePercentageOfAverageGrossAssets
0.034
CY2023 cik0001588272 Organization Costs And Offering Costs Are Limited To Percentage Of Total Gross Proceeds Raised In The Offering
OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering
0.01
CY2023Q4 cik0001588272 Cumulative Aggregate Amount Of Organization And Offering Costs
CumulativeAggregateAmountOfOrganizationAndOfferingCosts
5327574
CY2023 cik0001588272 Organization Costs And Offering Costs Are Limited To Percentage Of Total Gross Proceeds Raised In The Offering
OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering
0.01
CY2023 cik0001588272 Adviser Forfeited The Right To Reimbursement Of The Remaining Amount Of Costs Subsequent To Termination Of The Offering
AdviserForfeitedTheRightToReimbursementOfTheRemainingAmountOfCostsSubsequentToTerminationOfTheOffering
4305091
CY2023Q4 cik0001588272 Annual Retainer Amount Payable In Quarterly Installments To Related Party Oversees All Of The Portfolios In The Fund Complex
AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyOverseesAllOfThePortfoliosInTheFundComplex
150000
CY2023Q4 cik0001588272 Annual Retainer Amount Payable In Quarterly Installments To Related Party Who Does Not Oversees All Portfolios On Prorated Basis Of Who Oversees All Portfolios
AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyWhoDoesNotOverseesAllPortfoliosOnProratedBasisOfWhoOverseesAllPortfolios
150000
CY2023Q4 cik0001588272 Additional Payment Amount Eligible To Receive By Related Party Payable In Quarterly Installments
AdditionalPaymentAmountEligibleToReceiveByRelatedPartyPayableInQuarterlyInstallments
10000
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
15194
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
18170
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
17781
CY2023Q4 cik0001588272 Director Fee Expense Payable Amount
DirectorFeeExpensePayableAmount
0
CY2023 cik0001588272 Expense Reimbursements Amount That Are Eligible For Recoupment By The Adviser Expired
ExpenseReimbursementsAmountThatAreEligibleForRecoupmentByTheAdviserExpired
349488
CY2023Q4 cik0001588272 Percentage Of Distribution To Shareholders Investment Company Taxable Income
PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome
0.90
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.98
CY2023 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Assets
EffectiveIncomeTaxRateReconciliationDispositionOfAssets
0.982
CY2023Q4 cik0001588272 Paid In Capital Excess Of Par Value
PaidInCapitalExcessOfParValue
-19894
CY2022Q4 cik0001588272 Paid In Capital Excess Of Par Value
PaidInCapitalExcessOfParValue
-533512
CY2021Q4 cik0001588272 Paid In Capital Excess Of Par Value
PaidInCapitalExcessOfParValue
2104942
CY2023Q4 cik0001588272 Distributions In Excess Of Net Investment Income
DistributionsInExcessOfNetInvestmentIncome
-2103
CY2022Q4 cik0001588272 Distributions In Excess Of Net Investment Income
DistributionsInExcessOfNetInvestmentIncome
-308998
CY2021Q4 cik0001588272 Distributions In Excess Of Net Investment Income
DistributionsInExcessOfNetInvestmentIncome
1143870
CY2023Q4 cik0001588272 Accumulated Realized Gains
AccumulatedRealizedGains
21997
CY2022Q4 cik0001588272 Accumulated Realized Gains
AccumulatedRealizedGains
842510
CY2021Q4 cik0001588272 Accumulated Realized Gains
AccumulatedRealizedGains
-3248812
CY2023Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
0
CY2022Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
0
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
72812
CY2023Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
3674703
CY2022Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
-1567035
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
2708891
CY2023Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
0
CY2022Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
0
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
0
CY2023Q4 cik0001588272 Investment Company Distributable Earnings Loss Accumulated Other Temporary Differences
InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences
-848575
CY2022Q4 cik0001588272 Investment Company Distributable Earnings Loss Accumulated Other Temporary Differences
InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences
-883602
CY2021Q4 cik0001588272 Investment Company Distributable Earnings Loss Accumulated Other Temporary Differences
InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences
-910576
CY2023Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
36246978
CY2022Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
30814250
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
30077894
CY2023 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
1629804
CY2022 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
1526458
CY2021 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
3633179
CY2023 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
1757477
CY2022 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
1999373
CY2021 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
0
CY2023 cik0001588272 Investment Company Long Term Gain
InvestmentCompanyLongTermGain
0
CY2022 cik0001588272 Investment Company Long Term Gain
InvestmentCompanyLongTermGain
0
CY2021 cik0001588272 Investment Company Long Term Gain
InvestmentCompanyLongTermGain
0
CY2023Q4 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
9837724
CY2023Q4 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
6163021
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
3674703
CY2023Q4 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
45438583
CY2022Q4 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
7373938
CY2022Q4 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
8940973
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-1567035
CY2022Q4 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
54860750
CY2021Q4 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
4599564
CY2021Q4 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
1890673
CY2021Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
2708891
CY2021Q4 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
57527420
CY2023 cik0001588272 Percentage Of Income To Be Distributed To Shareholders Minimum
PercentageOfIncomeToBeDistributedToShareholdersMinimum
0.90
CY2023 cik0001588272 Excise Tax As A Percentage Of Income In Excess Of Dividend Distributions Per Annum
ExciseTaxAsAPercentageOfIncomeInExcessOfDividendDistributionsPerAnnum
0.04
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13020
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0089
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 cik0001588272 Share Repurchase Program
ShareRepurchaseProgram
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Note 6 — Share Repurchase Program </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On a quarterly basis, the Company intends to offer to repurchase shares of common stock on such terms as may be determined by the Board in its complete and absolute discretion unless, in the judgment of directors who are not “interested persons” of the Company (as defined in the 1940 Act), such repurchases would not be in the best interests of the Company’s stockholders or would violate applicable law. The Company will conduct such repurchase offers in accordance with the requirements of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13e-4</div> of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the 1940 Act. Any offer to repurchase shares of common stock will be conducted solely through tender offer materials furnished to each stockholder. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company currently intends to limit the number of shares of common stock to be repurchased during any calendar year to the number of shares of common stock it can repurchase with the proceeds it receives from the sale of shares of common stock under its distribution reinvestment plan. At the discretion of the Board, the Company may also use cash on hand, cash available from borrowings and cash from liquidation of securities investments as of the end of the applicable period to repurchase shares of common stock. In addition, the Company will limit the number of shares of common stock to be repurchased in any calendar year to 10.0% of the weighted average number of shares of common stock outstanding in the prior calendar year, or 2.5% in each quarter, though the actual number of shares of common stock that the Company offers to repurchase may be less in light of the limitations noted above. The Company intends to offer to repurchase such shares of common stock at a price (i) not less than the net asset value per share (the “NAV Per Share”) of the Company’s common stock next calculated following the Expiration Date, and (ii) not more than 2.5% greater than the NAV Per Share as of such date. The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 <div style="letter-spacing: 0px; top: 0px;;display:inline;">days</div>’ notice. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the first quarter of 2023 from February 23, 2023, until expiration of March 24, 2023,<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the first quarter tender offer, 181,298 shares of the Company were tendered for repurchase, constituting approximately 1.86% of the Company’s outstanding shares. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the second quarter of 2023 from May 19, 2023, until <div style="letter-spacing: 0px; top: 0px;;display:inline;">expiration of June 20, 2023</div>, at<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the second quarter tender offer, 179,159 shares of the Company were tendered for repurchase, constituting approximately 1.90% of the Company’s outstanding shares. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the third quarter of 2023 from August 23, 2023, until <div style="letter-spacing: 0px; top: 0px;;display:inline;">expiration of September 25, 2023</div>, at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the third quarter tender offer, 118,580 shares of the Company were tendered for repurchase, constituting approximately 1.20% of the Company’s outstanding shares. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the fourth quarter of 2023 from November 17, 2023, until <div style="letter-spacing: 0px; top: 0px;;display:inline;">expiration of December 18, 2023<div style="letter-spacing: 0px; top: 0px;;display:inline;">,</div></div> at 4:00<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the fourth quarter tender offer, 99,756 shares of the Company were tendered for repurchase, constituting approximately 1.05% of the Company’s outstanding shares. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the year ended December 31, 2023, the Company repurchased 0 shares as part of its death and disability repurchase program. </div>
CY2023Q4 cik0001588272 Minimum Limit Of Shares To Be Repurchased Percent
MinimumLimitOfSharesToBeRepurchasedPercent
0.10
CY2022Q1 cik0001588272 Minimum Limit Of Shares To Be Repurchased Percent
MinimumLimitOfSharesToBeRepurchasedPercent
0.025
CY2023Q4 cik0001588272 Percentage Of Shares To Be Issued Under Ceiling Limit Of Net Asset Value Per Share
PercentageOfSharesToBeIssuedUnderCeilingLimitOfNetAssetValuePerShare
0.025
CY2023Q4 cik0001588272 Minimum Notice Period Of Shares To Be Suspend Or Terminate
MinimumNoticePeriodOfSharesToBeSuspendOrTerminate
0.30
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2023 cik0001588272 Investment Companyfrom Return Of Capital Per Share
InvestmentCompanyfromReturnOfCapitalPerShare
-0.18
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
956291
CY2022Q4 cik0001588272 Affiliated Investment Owned At Fair Value
AffiliatedInvestmentOwnedAtFairValue
10273001
CY2023 cik0001588272 Investments In And Advance To Affiliates At Fair Value Gross Additions
InvestmentsInAndAdvanceToAffiliatesAtFairValueGrossAdditions
7911398
CY2023 cik0001588272 Investments In And Advance To Affiliates At Fair Value Gross Reductions
InvestmentsInAndAdvanceToAffiliatesAtFairValueGrossReductions
7802269
CY2023 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
68709
CY2023 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
314715
CY2023Q4 cik0001588272 Affiliated Investment Owned At Fair Value
AffiliatedInvestmentOwnedAtFairValue
10696845
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1453556
CY2023 cik0001588272 Affiliated Dividend Income
AffiliatedDividendIncome
837839
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.55
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
6.32
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
6.13
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
8.53
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
8.36
CY2023 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.17
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.18
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.19
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.24
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.3
CY2023 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.02
CY2022 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.59
CY2021 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.37
CY2020 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-2.22
CY2019 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.59
CY2023 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.15
CY2022 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.41
CY2021 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.56
CY2020 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.98
CY2019 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.89
CY2023 cik0001588272 Investment Companyfrom Net Investment Income Per Share
InvestmentCompanyfromNetInvestmentIncomePerShare
-0.18
CY2022 cik0001588272 Investment Companyfrom Net Investment Income Per Share
InvestmentCompanyfromNetInvestmentIncomePerShare
-0.16
CY2021 cik0001588272 Investment Companyfrom Net Investment Income Per Share
InvestmentCompanyfromNetInvestmentIncomePerShare
-0.37
CY2020 cik0001588272 Investment Companyfrom Net Investment Income Per Share
InvestmentCompanyfromNetInvestmentIncomePerShare
-0.42
CY2019 cik0001588272 Investment Companyfrom Net Investment Income Per Share
InvestmentCompanyfromNetInvestmentIncomePerShare
-0.6
CY2023 cik0001588272 Investment Company From Net Realized Gains Per Share
InvestmentCompanyFromNetRealizedGainsPerShare
0
CY2022 cik0001588272 Investment Company From Net Realized Gains Per Share
InvestmentCompanyFromNetRealizedGainsPerShare
0
CY2021 cik0001588272 Investment Company From Net Realized Gains Per Share
InvestmentCompanyFromNetRealizedGainsPerShare
0
CY2020 cik0001588272 Investment Company From Net Realized Gains Per Share
InvestmentCompanyFromNetRealizedGainsPerShare
0
CY2019 cik0001588272 Investment Company From Net Realized Gains Per Share
InvestmentCompanyFromNetRealizedGainsPerShare
-0.12
CY2022 cik0001588272 Investment Companyfrom Return Of Capital Per Share
InvestmentCompanyfromReturnOfCapitalPerShare
-0.2
CY2021 cik0001588272 Investment Companyfrom Return Of Capital Per Share
InvestmentCompanyfromReturnOfCapitalPerShare
0
CY2020 cik0001588272 Investment Companyfrom Return Of Capital Per Share
InvestmentCompanyfromReturnOfCapitalPerShare
0
CY2019 cik0001588272 Investment Companyfrom Return Of Capital Per Share
InvestmentCompanyfromReturnOfCapitalPerShare
0
CY2023 cik0001588272 Distributions Declared To Common Shareholders
DistributionsDeclaredToCommonShareholders
0.36
CY2022 cik0001588272 Distributions Declared To Common Shareholders
DistributionsDeclaredToCommonShareholders
0.36
CY2021 cik0001588272 Distributions Declared To Common Shareholders
DistributionsDeclaredToCommonShareholders
0.37
CY2020 cik0001588272 Distributions Declared To Common Shareholders
DistributionsDeclaredToCommonShareholders
0.42
CY2019 cik0001588272 Distributions Declared To Common Shareholders
DistributionsDeclaredToCommonShareholders
0.72
CY2023 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
0
CY2022 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
0
CY2021 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
0
CY2020 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
0
CY2019 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
0
CY2023 us-gaap Investment Company Repurchase Of Shares Per Share
InvestmentCompanyRepurchaseOfSharesPerShare
0
CY2022 us-gaap Investment Company Repurchase Of Shares Per Share
InvestmentCompanyRepurchaseOfSharesPerShare
0
CY2021 us-gaap Investment Company Repurchase Of Shares Per Share
InvestmentCompanyRepurchaseOfSharesPerShare
0
CY2020 us-gaap Investment Company Repurchase Of Shares Per Share
InvestmentCompanyRepurchaseOfSharesPerShare
0
CY2019 us-gaap Investment Company Repurchase Of Shares Per Share
InvestmentCompanyRepurchaseOfSharesPerShare
0
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.35
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.55
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
6.32
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
6.13
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
8.53
CY2023 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.032
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0665
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0912
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.2317
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1086
CY2023Q4 us-gaap Assets Net
AssetsNet
49810000
CY2022Q4 us-gaap Assets Net
AssetsNet
53694000
CY2021Q4 us-gaap Assets Net
AssetsNet
62939000
CY2020Q4 us-gaap Assets Net
AssetsNet
64190000
CY2019Q4 us-gaap Assets Net
AssetsNet
88936000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9309405
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9677593
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9956228
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10475168
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10425431
CY2023 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0412
CY2022 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0382
CY2021 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0378
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0399
CY2019 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0536
CY2023 us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0083
CY2022 us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0063
CY2021 us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0045
CY2020 us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0054
CY2019 us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0016
CY2023 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.032
CY2022 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0319
CY2021 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0333
CY2020 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0345
CY2019 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.052
CY2023 us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.024
CY2022 us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0243
CY2021 us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.025
CY2020 us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0341
CY2019 us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0333
CY2023 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0322
CY2022 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0306
CY2021 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0295
CY2020 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0395
CY2019 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.035
CY2023 cik0001588272 Investment Company Credit Facility Expenses To Average Net Assets
InvestmentCompanyCreditFacilityExpensesToAverageNetAssets
0
CY2022 cik0001588272 Investment Company Credit Facility Expenses To Average Net Assets
InvestmentCompanyCreditFacilityExpensesToAverageNetAssets
0
CY2021 cik0001588272 Investment Company Credit Facility Expenses To Average Net Assets
InvestmentCompanyCreditFacilityExpensesToAverageNetAssets
0
CY2020 cik0001588272 Investment Company Credit Facility Expenses To Average Net Assets
InvestmentCompanyCreditFacilityExpensesToAverageNetAssets
0.0027
CY2019 cik0001588272 Investment Company Credit Facility Expenses To Average Net Assets
InvestmentCompanyCreditFacilityExpensesToAverageNetAssets
0.0137
CY2023 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.09
CY2022 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.16
CY2021 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.13
CY2020 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.83
CY2019 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.42
CY2023 cik0001588272 Investment Companyasset Coverage Ratio
InvestmentCompanyassetCoverageRatio
0
CY2022 cik0001588272 Investment Companyasset Coverage Ratio
InvestmentCompanyassetCoverageRatio
0
CY2021 cik0001588272 Investment Companyasset Coverage Ratio
InvestmentCompanyassetCoverageRatio
0
CY2020 cik0001588272 Investment Companyasset Coverage Ratio
InvestmentCompanyassetCoverageRatio
0
CY2019 cik0001588272 Investment Companyasset Coverage Ratio
InvestmentCompanyassetCoverageRatio
2.41
CY2023 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0
CY2022 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0
CY2021 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0
CY2020 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.000328
CY2019 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.000331
CY2023 cik0001588272 Investment Companyshares Tendered Per Share
InvestmentCompanysharesTenderedPerShare
0.005
CY2023Q4 cik0001588272 Investment Company Investment Income Total
InvestmentCompanyInvestmentIncomeTotal
540182
CY2023Q3 cik0001588272 Investment Company Investment Income Total
InvestmentCompanyInvestmentIncomeTotal
1058773
CY2023Q2 cik0001588272 Investment Company Investment Income Total
InvestmentCompanyInvestmentIncomeTotal
918436
CY2023Q1 cik0001588272 Investment Company Investment Income Total
InvestmentCompanyInvestmentIncomeTotal
814832
CY2023Q4 cik0001588272 Investment Company Investment Income Loss Per Share Gross
InvestmentCompanyInvestmentIncomeLossPerShareGross
0.06
CY2023Q3 cik0001588272 Investment Company Investment Income Loss Per Share Gross
InvestmentCompanyInvestmentIncomeLossPerShareGross
0.11
CY2023Q2 cik0001588272 Investment Company Investment Income Loss Per Share Gross
InvestmentCompanyInvestmentIncomeLossPerShareGross
0.1
CY2023Q1 cik0001588272 Investment Company Investment Income Loss Per Share Gross
InvestmentCompanyInvestmentIncomeLossPerShareGross
0.08
CY2023Q4 us-gaap Net Investment Income
NetInvestmentIncome
109719
CY2023Q3 us-gaap Net Investment Income
NetInvestmentIncome
681628
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
512066
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
363521
CY2023Q4 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.01
CY2023Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.07
CY2023Q2 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.05
CY2023Q1 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.04
CY2023Q4 cik0001588272 Investment Company Gain Loss On Investment
InvestmentCompanyGainLossOnInvestment
1732521
CY2023Q3 cik0001588272 Investment Company Gain Loss On Investment
InvestmentCompanyGainLossOnInvestment
22833
CY2023Q2 cik0001588272 Investment Company Gain Loss On Investment
InvestmentCompanyGainLossOnInvestment
-627003
CY2023Q1 cik0001588272 Investment Company Gain Loss On Investment
InvestmentCompanyGainLossOnInvestment
-1341338
CY2023Q4 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.19
CY2023Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0
CY2023Q2 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.07
CY2023Q1 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.14
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1842240
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
704461
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-114937
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-977817
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.35
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.24
CY2023Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.26
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.36
CY2022Q4 cik0001588272 Investment Company Investment Income Total
InvestmentCompanyInvestmentIncomeTotal
584515
CY2022Q3 cik0001588272 Investment Company Investment Income Total
InvestmentCompanyInvestmentIncomeTotal
993592
CY2022Q2 cik0001588272 Investment Company Investment Income Total
InvestmentCompanyInvestmentIncomeTotal
1099896
CY2022Q1 cik0001588272 Investment Company Investment Income Total
InvestmentCompanyInvestmentIncomeTotal
1014610
CY2022Q4 cik0001588272 Investment Company Investment Income Loss Per Share Gross
InvestmentCompanyInvestmentIncomeLossPerShareGross
0.06
CY2022Q3 cik0001588272 Investment Company Investment Income Loss Per Share Gross
InvestmentCompanyInvestmentIncomeLossPerShareGross
0.1
CY2022Q2 cik0001588272 Investment Company Investment Income Loss Per Share Gross
InvestmentCompanyInvestmentIncomeLossPerShareGross
0.11
CY2022Q1 cik0001588272 Investment Company Investment Income Loss Per Share Gross
InvestmentCompanyInvestmentIncomeLossPerShareGross
0.1
CY2022Q4 us-gaap Net Investment Income
NetInvestmentIncome
113631
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
555608
CY2022Q2 us-gaap Net Investment Income
NetInvestmentIncome
629257
CY2022Q1 us-gaap Net Investment Income
NetInvestmentIncome
491122
CY2022Q4 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.01
CY2022Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.06
CY2022Q2 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.06
CY2022Q1 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.05
CY2022Q4 cik0001588272 Investment Company Gain Loss On Investment
InvestmentCompanyGainLossOnInvestment
257082
CY2022Q3 cik0001588272 Investment Company Gain Loss On Investment
InvestmentCompanyGainLossOnInvestment
-3208231
CY2022Q2 cik0001588272 Investment Company Gain Loss On Investment
InvestmentCompanyGainLossOnInvestment
-3557538
CY2022Q1 cik0001588272 Investment Company Gain Loss On Investment
InvestmentCompanyGainLossOnInvestment
653895
CY2022Q4 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.03
CY2022Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.32
CY2022Q2 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.36
CY2022Q1 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.07
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
370713
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2652623
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2928281
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1145017
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.55
CY2022Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.6
CY2022Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.96
CY2022Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
6.35

Files In Submission

Name View Source Status
0001193125-24-080440-index-headers.html Edgar Link pending
0001193125-24-080440-index.html Edgar Link pending
0001193125-24-080440.txt Edgar Link pending
0001193125-24-080440-xbrl.zip Edgar Link pending
cik0001588272-20231231.xsd Edgar Link pending
d777050d10k.htm Edgar Link pending
d777050dex311.htm Edgar Link pending
d777050dex312.htm Edgar Link pending
d777050dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g777050g72j41.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
cik0001588272-20231231_def.xml Edgar Link unprocessable
cik0001588272-20231231_lab.xml Edgar Link unprocessable
cik0001588272-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d777050d10k_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cik0001588272-20231231_cal.xml Edgar Link unprocessable